Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases

OBJECTIVE: Metformin has been linked to anti-proliferative and anti-inflammatory mechanisms. In this study, we aimed to examine the long-term impact of metformin on mortality and organ damage in patients with autoimmune diseases and type 2 diabetes mellitus (T2DM). METHODS: We conducted a cohort stu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Endocrinol (Lausanne)
Hlavní autoři: Lin, Chun-Yu, Wu, Chun-Hsin, Hsu, Chung-Yuan, Chen, Tien-Hsing, Lin, Ming-Shyan, Lin, Yu-Sheng, Su, Yu-Jih
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8104028/
https://ncbi.nlm.nih.gov/pubmed/33967957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.641635
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky